Export

EN
FR
Salbutamol
Essential medicine status
Section:
25. Medicines acting on the respiratory tract 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease
ATC codes: R03AC02
Indication
Chronic obstructive pulmonary disease ICD11 code: CA22
INN
Salbutamol
Medicine type
Chemical agent
List type
Core
Formulations
Parenteral > General injections > IV: 50 µg per mL in 5 mL ampoule (as sulfate)
Respiratory > Inhalation > aerosol: 100 µg per dose (as sulfate) ; 100 µg per dose (as sulfate) metered-dose inhaler
Respiratory > Inhalation > solution: 5 mg per mL (as sulfate) for use in nebulizers
EML status history
First added in 2003 (TRS 920)
Changed in 2009 (TRS 958)
Changed in 2011 (TRS 965)
Changed in 2021 (TRS 1035)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
terbutaline (ATC codes: R03CC03)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Salbutamol
DrugBank
Salbutamol
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended terbutaline be specified as a therapeutic alternative under the square box listing for salbutamol on the EML for this indication.